Brecanavir
Brecanavir (pronunciation: breh-KAN-uh-veer) is an experimental antiretroviral drug that was under development for the treatment of HIV and AIDS. It belongs to the class of drugs known as protease inhibitors, which work by blocking the action of an enzyme called protease, thereby preventing the virus from multiplying.
Etymology
The name "Brecanavir" is derived from the combination of the words "break" and "navirus", which symbolizes the drug's function of breaking the replication cycle of the virus.
Related Terms
- Antiretroviral therapy: The use of medications to manage HIV and prevent its progression to AIDS.
- Protease inhibitor: A type of antiretroviral drug that prevents the virus from replicating by blocking the action of an enzyme called protease.
- HIV: Human Immunodeficiency Virus, the virus that causes AIDS.
- AIDS: Acquired Immunodeficiency Syndrome, the most advanced stage of HIV infection.
External links
- Medical encyclopedia article on Brecanavir
- Wikipedia's article - Brecanavir
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski